Patents Assigned to CAMLOG BIOTECHNOLOGIES AG
  • Patent number: 9545293
    Abstract: The invention relates to an implant (10) serving to receive an abutment (110). The implant (10) has a receiving opening (15) in which a connection region (115) of the abutment (110) can be inserted. The receiving opening (15) and the connection region (115) have a conical section (17) or (117) and an indexing section (18) or (118). The total conical angle equals 6 to 20° and the indexing length f of the implant (10) or the indexing length F of the abutment (110) equals at least 90% of the conical section length k of the implant (10) or of the conical section length K of the abutment (110), typically more than 1.6 mm.
    Type: Grant
    Filed: January 13, 2011
    Date of Patent: January 17, 2017
    Assignee: CAMLOG BIOTECHNOLOGIES AG
    Inventors: David Sollberger, Christoph Solér, Alex Schär
  • Publication number: 20120301850
    Abstract: The invention relates to an implant (10) serving to receive an abutment (110). The implant (10) has a receiving opening (15) in which a connection region (115) of the abutment (110) can be inserted. The receiving opening (15) and the connection region (115) have a conical section (17) or (117) and an indexing section (18) or (118). The total conical angle equals 6 to 20° and the indexing length f of the implant (10) or the indexing length F of the abutment (110) equals at least 90% of the conical section length k of the implant (10) or of the conical section length K of the abutment (110), typically more than 1.6 mm.
    Type: Application
    Filed: January 13, 2011
    Publication date: November 29, 2012
    Applicant: CAMLOG BIOTECHNOLOGIES AG
    Inventors: David Sollberger, Christoph Solèr, Alex Schär
  • Publication number: 20090132048
    Abstract: An implant, in particular an implant for dental applications, is provided at least partially in the area of its surface with a protective layer. The protective layer is intended to avoid the deposition of contaminants. The protective layer is chosen such that it breaks up on contact with body fluids and/or bone, with the result that essentially no residues remain on the surface of the implant.
    Type: Application
    Filed: March 7, 2007
    Publication date: May 21, 2009
    Applicant: CAMLOG BIOTECHNOLOGIES AG
    Inventor: Alain J. Denzer